Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phl p 1 is the major allergen from timothy grass (*Phleum pratense*), a widely distributed grass species and a significant source of pollen allergy worldwide. It is a glycoprotein belonging to the group 1 family of grass pollen allergens. Recognized by IgE antibodies in more than 90% of individuals allergic to grass pollen, it serves as a key diagnostic marker. Phl p 1 triggers strong immune responses by inducing cytokine release from airway epithelial cells. It is localized in the cytoplasm and exine of mature timothy grass pollen grains and is released upon hydration. Unlike some other allergens, Phl p 1 does not possess protease activity; its allergenic effect primarily results from the induction of pro-inflammatory mediators.
Induction/release of pro-inflammatory mediators by airway epithelium; enhancement of TGF-beta expression. Does not possess protease activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Timothy Grass Major Allergen Phl p 1 (Phl p 1).